Illustration(s) pertain to the topic addressed in this publication, not the specific research or data presented in the publication

Vancomycin use in pediatric hematology-oncology patients

Abstract

Across-sectional study was performed of pediatric hematology-oncology patients who received vancomycin; use was compared to the Centers for Disease Control and Prevention (CDC) recommendations for vancomycin use. Thirty-seven patients received 308 doses of vancomycin. AR patients initially received vancomycin as empirical therapy; 100% of this use was not consistent with the CDC recommendations.

Hopkins HA, Sinkowitz-Cochran RL, Rudin BA, Keyserling HL, Jarvis WR

Infect Control Hosp Epidemiol 2000 Jan;21(1):48-50

PMID: 10656357

Vancomycin use in pediatric hematology-oncology patients was last modified: January 1st, 2000 by Hopkins HA, Sinkowitz-Cochran RL, Rudin BA, Keyserling HL, Jarvis WR